Tech Company M&A Transactions
Therapeutic Human Polyclonals Acquisition
On 4/2/2007, Therapeutic Human Polyclonals was acquired by Roche. The transaction price was $56.5 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/2/2007
Transaction Type
M&A
Amount
$56,500,000
M&A Terms
The transaction was all cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1444 Floyd Drive
Sunnyvale, CA 94087
USA
Sunnyvale, CA 94087
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/2/2007: Mimosa Systems venture capital transaction
Next: 4/3/2007: Radius Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs